Les tests antigéniques rapides au point d’intervention dans le dépistage de l’infection à SRAS-CoV-2
Wed, 22 Mar 2023 15:13:02 -0400
Italiano
Wed, 22 Mar 2023 15:13:02 -0400
Wed, 22 Mar 2023 15:08:17 -0400
Wed, 22 Mar 2023 14:32:28 -0400
Wed, 22 Mar 2023 14:26:11 -0400
Wed, 22 Mar 2023 14:16:30 -0400
Wed, 22 Mar 2023 14:10:57 -0400
Wed, 22 Mar 2023 13:57:38 -0400
Wed, 22 Mar 2023 13:51:01 -0400
Wed, 22 Mar 2023 10:01:50 -0400
Parsippany. New Jersey. Ascend Laboratories LLC. is voluntarily recalling Dabigatran Etcxilate Capsules. USP 75 mg and 150 mg to the consumer/user level due to the presence of a nitrosamine. N-nitroso-dabigatran, above the established Acceptable Daily Intake (ADI) level. To date, Ascend Laboratorie
80.211.154.110